Life Science Access Academy Ltd invites you to their event

Oncology and the New NHS

About this event

Cancer was highlighted in the NHS backlog plan but, as the challenges facing the NHS keep stacking up, will it remain centre stage?

In the new world of integrated care systems (ICSs) it would seem as though oncology is still receiving increasing focus, opening up even more opportunities for industry.

In this FREE 60-minute live event, we are joined by one of the Soar Beyond experts to explore how ICSs will impact oncology within the NHS.

We will hear from an NHS Oncology Expert to discuss the decisions and tactics that Life Sciences needs to look out for when working within this sector.

This session will cover:

  • Cancer as a priority in the NHS backlog plan – where next?
  • What are some of the likely tactical measures the NHS may deploy on national, regional or local levels?
  • How will the NHS interpret the changes relating to ICSs?
  • What impact will this have on the industry?
  • Will decisions made about adoption of oncology treatments be national or local?
  • How will these decisions be implemented?

Book your space now!

Hosted by

  • Team member
    T
    Ian Chamberlain Managing Director @ Life Science Access Academy

    Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.

  • Guest speaker
    G
    Jatinder Harchowal Chief Pharmacist

    Jatinder Harchowal has been a Chief Pharmacist for over 18 years having worked at Ealing Hospital, Brighton & Sussex University Hospitals, The Royal Marsden and now University College London Hospitals NHS Foundation Trust (UCLH). In March 2020, Jatinder was seconded as Director of Pharmacy for the Nightingale Hospital, leading the set up and running of a 24 hour-7 day medicines optimisation service to help support the COVID-19 pandemic. Jatinder has also supported health systems across the world with the safe introduction and adoption of Biosimilars. Jatinder is the Chair of the Royal Pharmaceutical Society’s Hospital Expert Advisory Group (HEAG) and is an appointed member of the King’s Fund Advisory Board. He is a Health Foundation Fellow and was awarded a Fellowship for the Royal Pharmaceutical Society. In October 2020, Jatinder was awarded an MBE in the Queen’s Birthday Honours for his work during the COVID-19 pandemic and services to the pharmaceutical profession.

  • Guest speaker
    G
    Shailen Rao Managing Director @ Soar Beyond

    Managing Director of Soar Beyond who has a wealth of experience in NHS medicines optimisation, service pathway development, and pharma market access along with Soar Beyonds NHS experts associates.

Life Science Access Academy Ltd

LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.